PRESS RELEASE published on 03/07/2025 at 08:29, 1 year 8 months ago Inside Information / Operations of the issuer (acquisitions, sales...) GenSight Biologics announces c. €0.9 million financing round for innovative gene therapy program. Financing from existing investors supports LUMEVOQ access for patients. Business update includes 2024 annual results and working capital statement Financing Business Update Gene Therapy GenSight Biologics LUMEVOQ
PRESS RELEASE published on 03/07/2025 at 08:29, 1 year 8 months ago Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...) GenSight Biologics annonce un financement de 0,9 million d'euros auprès d'investisseurs existants. Augmentation de capital pour avancer ses recherches thérapeutiques essentielles Financement GenSight Biologics Thérapies Géniques Investisseurs Existants Recherche Thérapeutique
PRESS RELEASE published on 03/07/2025 at 08:00, 1 year 8 months ago Transaction in Own Shares Molten Ventures plc announces purchase of 50,000 Ordinary Shares at various prices as part of share repurchase program. Details of transactions provided Transactions Share Repurchase Ordinary Shares Molten Ventures Plc Numis Securities
PRESS RELEASE published on 03/07/2025 at 08:00, 1 year 8 months ago Changes in the Executive Board of FUCHS SE Changes in the Executive Board of FUCHS SE as Isabelle Adelt and Dr. Sebastian Heiner will not extend contracts. New CFO Esma Saglik and CTO Mathieu Boulandet appointed. Smooth transition expected Executive Board FUCHS SE Transition Isabelle Adelt Dr. Sebastian Heiner
PRESS RELEASE published on 03/07/2025 at 07:30, 1 year 8 months ago AUSTRIAN POST IN 2024: Revenue and earnings increase in all divisions Austrian Post AG reports revenue and earnings increase in all divisions for the year 2024, with positive trends from elections and exchange rates. Dividend proposed for 2025. Focus on growing markets and efficiency for upcoming years Revenue Dividend 2024 Earnings Divisions Austrian Post AG
PRESS RELEASE published on 03/07/2025 at 07:30, 1 year 8 months ago Zalando has secured more than 90% of ABOUT YOU’s share capital without treasury shares and announces firm intention to implement a squeeze-out of minority shareholders of ABOUT YOU Zalando announces intention to squeeze out minority shareholders of ABOUT YOU after securing more than 90% of share capital Minority Shareholders Zalando Public Takeover ABOUT YOU Squeeze Out
PRESS RELEASE published on 03/07/2025 at 07:30, 1 year 8 months ago Informations privilégiées / Autres communiqués Sensorion annonce la fin du recrutement des patients dans NOTOXIS, essai clinique Phase 2a SENS-401 pour prévenir ototoxicité cisplatine. Résultats NOTOXIS attendus fin 2025 Phase 2a Sensorion SENS-401 Ototoxicité NOTOXIS
PRESS RELEASE published on 03/07/2025 at 07:30, 1 year 8 months ago Inside Information / Other news releases Sensorion completes patient enrollment in NOTOXIS Phase 2a Clinical Trial of SENS-401 for Cisplatin-Induced Ototoxicity prevention, targeting a significant unmet medical need Clinical Trial Sensorion SENS-401 NOTOXIS Cisplatin-Induced Ototoxicity
PRESS RELEASE published on 03/07/2025 at 07:30, 1 year 8 months ago Atos launches a reverse stock split Atos implements reverse stock split to normalize share count, reduce volatility, and support market dynamics. Details of the operation and impact on shareholders Shareholders Reverse Stock Split Volatility Market Dynamics Atos
PRESS RELEASE published on 03/07/2025 at 07:30, 1 year 8 months ago Atos lance le regroupement de ses actions Atos annonce le regroupement d'actions pour stabiliser le cours et dynamiser la bourse. Détails des modalités et calendrier inclus Actions Bourse Modalités Atos Regroupement
Published on 11/06/2026 at 22:15, 2 days 1 hour ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 10 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 11 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 11 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/08/2026 at 12:10, 11 hours 27 minutes ago GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap
Published on 11/08/2026 at 10:15, 13 hours 22 minutes ago 2026 China International Intelligent Communication Forum Held in Wuxi
Published on 11/07/2026 at 13:35, 1 day 10 hours ago Eurobattery Minerals board member and CEO remanded in custody in Sweden
Published on 11/06/2026 at 20:15, 2 days 3 hours ago African Medicines Agency Marks First Year of Operations with New Platforms to Strengthen Regulation and Support Manufacturing
Published on 11/06/2026 at 20:15, 2 days 3 hours ago L’Agence africaine des médicaments marque sa première année d’activité avec le lancement de nouvelles plateformes pour renforcer la réglementation et soutenir la fabrication
Published on 11/06/2026 at 19:06, 2 days 4 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:04, 2 days 4 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 11/06/2026 at 19:01, 2 days 4 hours ago ALTAREA : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
Published on 11/06/2026 at 19:00, 2 days 4 hours ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL